These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30139984)

  • 1. The effect of Ganoderma lucidum extract on immunological function and identify its anti-tumor immunostimulatory activity based on the biological network.
    Zhao R; Chen Q; He YM
    Sci Rep; 2018 Aug; 8(1):12680. PubMed ID: 30139984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecule mechanisms of Ganoderma lucidum treated hepatocellular carcinoma based on the transcriptional profiles and miRNA-target network.
    Tang C; Zhao R; Ni H; Zhao K; He Y; Fang S; Chen Q
    Biomed Pharmacother; 2020 May; 125():110028. PubMed ID: 32106374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
    Zhao RL; He YM
    J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory Effects of Chitooligosaccharides on RAW 264.7 Mouse Macrophages via Regulation of the MAPK and PI3K/Akt Signaling Pathways.
    Yang Y; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30626153
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ren Z; Ding H; Zhou M; Chan P
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145248
    [No Abstract]   [Full Text] [Related]  

  • 6. A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial-mesenchymal transition.
    Li L; Guo HJ; Zhu LY; Zheng L; Liu X
    Phytomedicine; 2016 May; 23(5):491-7. PubMed ID: 27064008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo hepatoprotective effect of ganodermanontriol against t-BHP-induced oxidative stress.
    Ha do T; Oh J; Khoi NM; Dao TT; Dung le V; Do TN; Lee SM; Jang TS; Jeong GS; Na M
    J Ethnopharmacol; 2013 Dec; 150(3):875-85. PubMed ID: 24140584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice.
    Wu YW; Fang HL; Lin WC
    Phytother Res; 2010 Apr; 24(4):494-9. PubMed ID: 19621343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential immunological activities of Ganoderma lucidum on human pre-cancerous uroepithelial cells.
    Yuen JW; Gohel MD; Ng CF
    J Ethnopharmacol; 2011 Jun; 135(3):711-8. PubMed ID: 21501679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models.
    Weng CJ; Chau CF; Yen GC; Liao JW; Chen DH; Chen KD
    J Agric Food Chem; 2009 Jun; 57(11):5049-57. PubMed ID: 19422227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Possible Role of PD-1 Protein in
    Wang G; Wang L; Zhou J; Xu X
    Integr Cancer Ther; 2019; 18():1534735419880275. PubMed ID: 31595795
    [No Abstract]   [Full Text] [Related]  

  • 12. The Efficacy of Ganoderma lucidum Extracts on Treating Endometrial Cancer: A Network Pharmacology Approach.
    Shi M
    Reprod Sci; 2024 Jul; 31(7):1881-1894. PubMed ID: 38448739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells.
    Xie JT; Wang CZ; Wicks S; Yin JJ; Kong J; Li J; Li YC; Yuan CS
    Exp Oncol; 2006 Mar; 28(1):25-9. PubMed ID: 16614703
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Acevedo-Díaz A; Ortiz-Soto G; Suárez-Arroyo IJ; Zayas-Santiago A; Martínez Montemayor MM
    Nutrients; 2019 May; 11(5):. PubMed ID: 31109134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis.
    Xi JC; Zang HY; Guo LX; Xue HB; Liu XD; Bai YB; Ma YZ
    J Recept Signal Transduct Res; 2015; 35(6):640-5. PubMed ID: 26390889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganoderma lucidum induced apoptosis in NB4 human leukemia cells: involvement of Akt and Erk.
    Calviño E; Manjón JL; Sancho P; Tejedor MC; Herráez A; Diez JC
    J Ethnopharmacol; 2010 Mar; 128(1):71-8. PubMed ID: 20036724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Cytokine; 2012 Oct; 60(1):38-42. PubMed ID: 22840496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.